2-(4-chlorobenzoyl)-N-(3-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide

ID: ALA4849116

PubChem CID: 164610524

Max Phase: Preclinical

Molecular Formula: C23H19ClN2O3

Molecular Weight: 406.87

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cccc(O)c1)C1c2ccccc2CCN1C(=O)c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C23H19ClN2O3/c24-17-10-8-16(9-11-17)23(29)26-13-12-15-4-1-2-7-20(15)21(26)22(28)25-18-5-3-6-19(27)14-18/h1-11,14,21,27H,12-13H2,(H,25,28)

Standard InChI Key:  MEFGFBXAHZTNTE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   26.7554  -25.1472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7543  -25.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4623  -26.3757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4605  -24.7383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1691  -25.1436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1699  -25.9626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8784  -26.3696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5867  -25.9588    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.5820  -25.1367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8729  -24.7333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8801  -27.1868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1733  -27.5969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.5887  -27.5940    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.1750  -28.4141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4665  -28.8190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4678  -29.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1769  -30.0434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8861  -29.6289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8813  -28.8139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5961  -30.0336    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.2960  -26.3647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2992  -27.1819    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.0021  -25.9533    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.7086  -26.3636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4142  -25.9529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.4115  -25.1349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6972  -24.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9945  -25.1422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1170  -24.7226    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
  7 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 18 20  1  0
  8 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 26 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4849116

    ---

Associated Targets(Human)

NUGC-3 (976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.87Molecular Weight (Monoisotopic): 406.1084AlogP: 4.42#Rotatable Bonds: 3
Polar Surface Area: 69.64Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.23CX Basic pKa: CX LogP: 4.46CX LogD: 4.45
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.68Np Likeness Score: -0.92

References

1. Sim S, Lee S, Ko S, Phuong Bui B, Linh Nguyen P, Cho J, Lee K, Kang JS, Jung JK, Lee H..  (2021)  Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.,  46  [PMID:34500188] [10.1016/j.bmc.2021.116371]

Source